SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
78.50
+0.20 (0.26%)
Aug 12, 2025, 12:57 PM CST
0.26%
Market Cap4.73B
Revenue (ttm)970.18M
Net Income (ttm)118.57M
Shares Out60.39M
EPS (ttm)1.96
PE Ratio39.95
Forward PEn/a
Dividend1.33 (1.75%)
Ex-Dividend DateJul 16, 2025
Volume75,008
Average Volume121,571
Open77.00
Previous Close78.30
Day's Range76.70 - 79.10
52-Week Range48.60 - 95.70
Beta-0.10
RSI80.82
Earnings DateAug 11, 2025

About Splunk

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Founded 2007
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.

Financial Statements

News

There is no news available yet.